Zobrazeno 1 - 10
of 819
pro vyhledávání: '"Papasouliotis O"'
Publikováno v:
Journal of the Royal Statistical Society. Series A (Statistics in Society), 1997 Jan 01. 160(2), 333-350.
Externí odkaz:
https://www.jstor.org/stable/2983224
Autor:
Pitsiu M; Quantitative Pharmacology and Pharmacometrics, ICON Clinical Research UK Ltd, Marlow, UK., Yalkinoglu Ö; Translational Medicine, the healthcare business of Merck KGaA, Darmstadt, Germany., Farrell C; Quantitative Pharmacology and Pharmacometrics, ICON Clinical Research UK Ltd, Marlow, UK., Girard P; Merck Institute of Pharmacometrics, Lausanne, Switzerland, an Affiliate of Merck KGaA, Darmstadt, Germany, Ares Trading S.A., Lausanne, Switzerland., Vazquez-Mateo C; Global Clinical Development, EMD Serono, Billerica, Massachusetts, USA., Papasouliotis O; Merck Institute of Pharmacometrics, Lausanne, Switzerland, an Affiliate of Merck KGaA, Darmstadt, Germany, Ares Trading S.A., Lausanne, Switzerland.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Aug; Vol. 12 (8), pp. 1157-1169. Date of Electronic Publication: 2023 Jun 18.
Publikováno v:
In Journal of Pharmaceutical Sciences January 2010 99(1):524-538
Autor:
Eslami M; Department of Immunobiology, University of Lausanne, Epalinges, Switzerland., Willen D; Clinical Pharmacology, Translational Medicine, Merck Healthcare KGaA, Darmstadt, Germany., Papasouliotis O; Translational Medicine, Merck Institute for Pharmacometrics (an affiliate of Merck KGaA), Lausanne, Switzerland., Schuepbach-Mallpell S; Department of Immunobiology, University of Lausanne, Epalinges, Switzerland., Willen L; Department of Immunobiology, University of Lausanne, Epalinges, Switzerland., Donzé O; Adipogen Life Sciences, Epalinges, Switzerland., Yalkinoglu Ö; Clinical Pharmacology, Translational Medicine, Merck Healthcare KGaA, Darmstadt, Germany., Schneider P; Department of Immunobiology, University of Lausanne, Epalinges, Switzerland.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Dec 02; Vol. 13, pp. 1035556. Date of Electronic Publication: 2022 Dec 02 (Print Publication: 2022).
Autor:
Papasouliotis O; Merck Institute for Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany., Mitchell D; Certara, Broomfield, Colorado, USA., Girard P; Merck Institute for Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany., Dyroff M; EMD Serono, Billerica, Massachusetts, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2022 Dec; Vol. 15 (12), pp. 2899-2908. Date of Electronic Publication: 2022 Oct 17.
Autor:
Papasouliotis O; Merck Institute for Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany., Mitchell D; Certara, Broomfield, Colorado, USA., Girard P; Merck Institute for Pharmacometrics, Lausanne, Switzerland, an affiliate of Merck KGaA, Darmstadt, Germany., Dangond F; EMD Serono, Billerica, Massachusetts, USA., Dyroff M; EMD Serono, Billerica, Massachusetts, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2022 Dec; Vol. 15 (12), pp. 2888-2898. Date of Electronic Publication: 2022 Sep 30.
Autor:
Xiong W; Merck Institute of Pharmacometrics, Lausanne, Switzerland., Hietala SF; Pharmetheus AB, Uppsala, Sweden., Nyberg J; Pharmetheus AB, Uppsala, Sweden., Papasouliotis O; Merck Institute of Pharmacometrics, Lausanne, Switzerland., Johne A; Merck Healthcare KGaA, Darmstadt, Germany., Berghoff K; Merck Healthcare KGaA, Darmstadt, Germany., Goteti K; EMD Serono Research and Development Institute Inc., Billerica, MA, USA., Dong J; EMD Serono Research and Development Institute Inc., Billerica, MA, USA., Girard P; Merck Institute of Pharmacometrics, Lausanne, Switzerland., Venkatakrishnan K; EMD Serono Research and Development Institute Inc., Billerica, MA, USA., Strotmann R; Merck Healthcare KGaA, Darmstadt, Germany. rainer.strotmann@merckgroup.com.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 Jul; Vol. 90 (1), pp. 53-69. Date of Electronic Publication: 2022 Jun 30.
Autor:
Xiong W; Merck Institute of Pharmacometrics, Merck KGaA, Lausanne, Switzerland.; UCB, Bulle, Switzerland., Papasouliotis O; Merck Institute of Pharmacometrics, Merck KGaA, Lausanne, Switzerland. orestis.papasouliotis@merckgroup.com., Jonsson EN; Pharmetheus AB, Uppsala, Sweden., Strotmann R; Quantitative Pharmacology, Merck Healthcare KGaA, Darmstadt, Germany., Girard P; Merck Institute of Pharmacometrics, Merck KGaA, Lausanne, Switzerland.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2022 May; Vol. 89 (5), pp. 655-669. Date of Electronic Publication: 2022 Apr 06.
Autor:
Kareva I; Quantitative Pharmacology Department, EMD Serono Research and Development Institute, 45A Middlesex Turnpike, Billerica, MA, 01821, USA. Irina.Kareva@emdserono.com., Zutshi A; Quantitative Pharmacology Department, EMD Serono Research and Development Institute, 45A Middlesex Turnpike, Billerica, MA, 01821, USA., Mateo CV; Quantitative Pharmacology Department, EMD Serono Research and Development Institute, 45A Middlesex Turnpike, Billerica, MA, 01821, USA., Papasouliotis O; Merck Institute for Pharmacometrics (an affiliate of Merck KGaA, Darmstadt, Germany), Lausanne, Switzerland.
Publikováno v:
European journal of drug metabolism and pharmacokinetics [Eur J Drug Metab Pharmacokinet] 2021 Nov; Vol. 46 (6), pp. 827.
Autor:
Xiong, W. 1, Hietala, S. 2, Nyberg, J. 2, Papasouliotis, O. 1, Anziano, R. 2, Berghoff, K. 3, Johne, A. 4, Girard, P. 1, Strotmann, R. 5, Paik, P. 6
Publikováno v:
In Journal of Thoracic Oncology January 2021 16(1) Supplement:S36-S36